Inventory Disclosure [Abstract]
Inventory
Inventory Disclosure [Text Block]
Balance Sheet Parenthetical [Abstract]
Balance Sheet Parenthetical [Abstract]
Common stock, par value
Common Stock, Par or Stated Value Per Share
Common stock, shares authorized
Common Stock, Shares Authorized
Common stock, shares issued
Common Stock, Shares, Issued
Common stock, shares outstanding
Common Stock, Shares, Outstanding
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Restructuring and Related Costs [Table]
Schedule of Restructuring and Related Costs [Table]
Restructuring Type [Axis]
Restructuring Type [Axis]
Restructuring Plan [Domain]
Restructuring Plan [Domain]
Minimum
Minimum [Member]
Maximum
Maximum [Member]
Restructuring Reserve Disclosures [Line Items]
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected expense reduction
Restructuring and Related Cost, Expected Expense Reduction
Anticipated amount of expense reduction associated with exit or disposal activities pursuant to an authorized plan.
Restructuring and related cost, expected cost
Restructuring and Related Cost, Expected Cost
Restructuring and related cost, expected cash outlays
Restructuring and Related Cost, Expected Cash Outlays
Amount expected to be recognized in expenses for the specified restructuring cost to result in cash outlays.
Procurement Contract [Abstract]
Procurement Contract [Abstract]
Procurement Contract [Abstract]
Number of courses delivered
Government Contract, number of courses delivered
Courses of Arestvyr delivered to the Strategic Stockpile
Contract receivable collected, delivered product
Contract Receivable Collected, Delivered Products
Amount billed to customers under long-term contracts or programs and collected for delivered product. Excludes amounts due that have been withheld because of retainage provisions in a contract.
Earnings Per Share [Abstract]
Schedule of earnings per share, basic and diluted
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Schedule of antidilutive securities excluded from computation of earnings per share
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Commitments and Contingencies Disclosure [Abstract]
Loss Contingencies [Table]
Loss Contingencies [Table]
Litigation Case [Axis]
Litigation Case [Axis]
Litigation Case Type [Domain]
Litigation Case [Domain]
License Agreement litigation
License Agreement Litigation [Member]
License Agreement Litigation [Member]
Litigation Status [Axis]
Litigation Status [Axis]
Litigation Status [Domain]
Litigation Status [Domain]
Pending litigation
Pending Litigation [Member]
Loss Contingency Nature [Axis]
Loss Contingency Nature [Axis]
Loss Contingency, Nature [Domain]
Loss Contingency, Nature [Domain]
Surety bond
Surety Bond [Member]
Balance Sheet Location [Axis]
Balance Sheet Location [Axis]
Balance Sheet Location [Domain]
Balance Sheet Location [Domain]
Accrued liabilities
Accrued Liabilities [Member]
Other assets
Other Assets [Member]
Loss Contingencies [Line Items]
Loss Contingencies [Line Items]
Percentage of net profits from sales after net profit threshold
Percentage of Net Profits from Sales After Net Profit Milestone Resulting From Award Damages
The Delaware Court of Chancery awarded to PharmAthene an equitable payment stream or equitable lien consisting of fify percent of the net profits that the Company achieves from sales of ST-246 after the Company secures $40 million in net profits, for ten years following the first commercial sale.
Net profit threshold
Net Profit Milestone
The Delaware Court of Chancery awarded to PharmAthene an equitable payment stream or equitable lien consisting of fify percent of the net profits that the Company achieves from sales of ST-246 after the Company secures $40 million in net profits, for ten years following the first commercial sale
Equitable payment stream following first commercial sale, duration
Duration of Equitable Payment Stream Following First Commercial Sale
The Delaware Court of Chancery awarded to PharmAthene an equitable payment stream or equitable lien consisting of fify percent of the net profits that the Company achieves from sales of ST-246 after the Company secures $40 million in net profits, for ten years following the first commercial sale.
Percentage of litigation costs awarded
Litigation Costs Awarded, Percentage
The Delaware Court of Chancery awarded PharmAthene one-third of its reasonable attorneys' fees and expert witness expenses.
Plaintiff attorneys' fee and expenses
Amount Plaintiff May Recover
The Delaware Court of Chancery awarded PharmAthene one-third of its reasonable attorneys' fees and expert witness expenses.
Accrued liabilities, current
Loss Contingency Accrual
Payment to post collateral for surety bond
Payment to Post Collateral for Surety Bond
Payment to post collateral for surety bond.
Statement of Financial Position [Abstract]
ASSETS
Assets [Abstract]
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value
Accounts receivable
Accounts Receivable, Net, Current
Contract receivable, due in next twelve months
Contract Receivable, Due in Next Twelve Months
Inventory
Inventory, Net
Prepaid expense and other assets, current
Prepaid Expense and Other Assets, Current
Deferred tax assets
Deferred Tax Assets, Net of Valuation Allowance, Current
Total current assets
Assets, Current
Property, plant and equipment, net
Property, Plant and Equipment, Net
Contract receivable
Contract Receivable
Deferred costs
Deferred Costs, Noncurrent
Goodwill
Goodwill
Other assets
Other Assets, Noncurrent
Deferred tax assets, net
Deferred Tax Assets, Net of Valuation Allowance, Noncurrent
Total assets
Assets
LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities and Equity [Abstract]
Accounts payable
Accounts Payable, Current
Accrued expenses and other current liabilities
Accrued Liabilities, Current
Common stock warrants, current
Common Stock Warrants, Current, Fair Value Disclosure
This item represents current portion of a security that gives the holder the right to purchase shares of common stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Long-term debt, current maturities
Long-term Debt, Current Maturities
Total current liabilities
Liabilities, Current
Deferred revenue
Deferred Revenue, Noncurrent
Common stock warrants, noncurrent
Common Stock Warrants, Noncurrent, Fair Value Disclosure
This item represents non-current portion of a security that gives the holder the right to purchase shares of common stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Long-term debt, excluding current maturities
Long-term Debt, Excluding Current Maturities
Other liabilities
Other Liabilities
Total liabilities
Liabilities
Stockholders' equity
Stockholders' Equity Attributable to Parent [Abstract]
Common stock ($.0001 par value, 100,000,000 shares authorized, 52,396,497 and 51,642,520 issued and outstanding at September 30, 2013, and December 31, 2012, respectively)
Common Stock, Value, Issued
Additional paid-in capital
Additional Paid in Capital, Common Stock
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Total stockholders' equity
Stockholders' Equity Attributable to Parent
Total liabilities and stockholders' equity
Liabilities and Equity
Equity [Abstract]
Class of Warrant or Right [Table]
Class of Warrant or Right [Table]
Measurement Frequency [Axis]
Measurement Frequency [Axis]
Fair Value, Measurement Frequency [Domain]
Fair Value, Measurement Frequency [Domain]
Fair Value, Measurements, Recurring [Member]
Fair Value, Measurements, Recurring [Member]
Fair Value, Hierarchy [Axis]
Fair Value, Hierarchy [Axis]
Fair Value Hierarchy [Domain]
Fair Value Hierarchy [Domain]
Fair Value, Inputs, Level 2 [Member]
Fair Value, Inputs, Level 2 [Member]
Scenario [Axis]
Scenario [Axis]
Scenario, Unspecified [Domain]
Scenario, Unspecified [Domain]
Extended Expiration Period [Member]
Extended Expiration Period [Member]
Extended Expiration Period [Member]
Related Party [Axis]
Related Party [Axis]
Related Party [Domain]
Related Party [Domain]
Affiliated Entity
Affiliated Entity [Member]
Class of Warrant or Right [Line Items]
Class of Warrant or Right [Line Items]
Common stock warrants, current and noncurrent
Common Stock Warrants, Current and Noncurrent, Fair Value Disclosure
This item represents current and noncurrent portion of a security that gives the holder the right to purchase shares of common stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Change In fair value of common stock warrants
Change In Fair Value Of Common Stock Warrants
The aggregate adjustment to the fair market value of liability classified warrants to purchase common stock.
Service agreement term
Service Agreement Term
Service Agreement Term in years.
Warrants to purchase common stock
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Exercise price of warrants to purchase common stock
Class of Warrant or Right, Exercise Price of Warrants or Rights
Warrants contractual term (in years)
Warrants contractrual term
The contractual life of warrants.
Commitment to Invest
Commitment to Invest
Related party commitment to invest at the Company's discretion in exhange for common stock and warrants.
Warrants to purchase percentage of acquired shares
Warrants to Purchase Percentage of Shares
Related party commitment to invest at the Company's discretion in exhange for warrants to purchase a percentage of the number of Company shares acquired by the related party.
Proceeds from issuance of warrants and options
Proceeds From Issuance Of Warrants and Options 1
The cash inflow associated with both the amount received from holders exercising their stock options and issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.
Warrants exercised
Warrants exercised
Warrants exercised
Warrants, outstanding
Class of Warrant or Right, Outstanding
Capital units, authorized
Capital Units, Authorized
Preferred stock, shares authorized
Preferred Stock, Shares Authorized
Property, Plant and Equipment [Abstract]
Property, plant and equipment
Property, Plant and Equipment [Table Text Block]
Fair Value Disclosures [Abstract]
Fair Value Measurements, Recurring and Nonrecurring [Table]
Fair Value Measurements, Recurring and Nonrecurring [Table]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Common stock warrants, current and noncurrent
Term loan
Debt, Long-term and Short-term, Combined Amount
Per Share Data
Earnings Per Share [Text Block]
Procurement Contract [Table]
Procurement Contract [Table]
Procurement Contract [Table]
Procurement Contract [Axis]
Procurement Contract [Axis]
Procurement Contract [Axis]
Procurement Contract [Domain]
Procurement Contract [Domain]
Procurement Contract [Domain]
BARDA Contract
Barda Contract [Member]
Barda Contract [Member]
Procurement Contract [Line Items]
Procurement Contract [Line Items]
Procurement Contract [Line Items]
Courses delivered
Courses delivered
Courses of Arestvyr delivered to the Strategic Stockpile.
Recent Accounting Pronouncements [Abstract]
Recent Accounting Pronouncements [Abstract]
New Accounting Pronouncements, Policy
New Accounting Pronouncements, Policy [Policy Text Block]
Payables and Accruals [Abstract]
Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities [Text Block]
The entire disclosure for accrued liabilities and other current liabilities at the end of the reporting period.
Condensed Consolidated Statement of Operations [Abstract]
Condensed Consolidated Statement of Operations [Abstract]
Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]
Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]
As Originally Reported
Scenario, Previously Reported [Member]
Adjustments
Revised Adjustment [Member]
Amounts represent revised, rather than restated, adjustments due to the immaterial nature of such adjustments, and the resulting effect of a correction of an error on a financial statement line item or any per share amounts. The cumulative effect of the change on retained earnings or net assets in the statement of financial position would also be represented under this domain member.
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Research and development
Research and Development Revenue
Revenue earned during the period arising from services provided under the terms of a contract, not elsewhere specified in the taxonomy. May include government contracts and any other contract related to a particular project or product.
Selling, general and administrative
Selling, General and Administrative Expense
Research and development
Research and Development Expense
Patent preparation fees
Patent Preparation Fees
The aggregate costs incurred for fees associated with the protection and expansion of patents and related intellectual property.
Total operating expenses
Operating Expenses
Operating loss
Operating Income (Loss)
Other income, net
Nonoperating Income (Expense)
Loss before income taxes
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest
Benefit from income taxes
Income Tax Expense (Benefit)
Net income (loss)
Net Income (Loss) Attributable to Parent
Earnings Per Share, Basic and Diluted
Earnings Per Share, Basic and Diluted
Weighted Average Number of Shares Outstanding, Basic and Diluted
Weighted Average Number of Shares Outstanding, Basic and Diluted
Revision of Consolidated Financial Statements [Abstract]
Revision of Consolidated Financial Statements [Abstract]
Accounting Changes and Error Corrections
Accounting Changes and Error Corrections [Text Block]
Income Tax Disclosure [Abstract]
Income Tax
Income Tax Disclosure [Text Block]
Interim Condensed Consolidated Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Laboratory Equipment, Gross
Machinery and Equipment, Gross
Leasehold Improvements, Gross
Leasehold Improvements, Gross
Computer Equipment, Gross
Computer Equipment
The gross amount of capitalized computer equipment costs as of the balance sheet date.
Furniture and Fixtures, Gross
Furniture and Fixtures, Gross
Property, Plant and Equipment, Gross
Property, Plant and Equipment, Gross
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Property, Plant and Equipment, Net
Property, Plant and Equipment
Property, Plant and Equipment Disclosure [Text Block]
Statement of Cash Flows [Abstract]
Statement [Table]
Statement [Table]
Statement [Line Items]
Statement [Line Items]
Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]
Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]
Cash flows from operating activities:
Net Cash Provided by (Used in) Operating Activities [Abstract]
Net income (loss)
Adjustments to reconcile net income (loss) to net cash used in operating activities
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Depreciation and other amortization
Depreciation, Depletion and Amortization
Increase (decrease) in fair value of warrants
Increase In Fair Value Of Warrants
Noncash expense, not otherwise specified in the taxonomy, charged against earnings in the period to adjust the fair market value of liability classified warrants to purchase common stock.
Stock based compensation
Share-based Compensation
Amortization of Debt Discount (Premium)
Amortization of Debt Discount (Premium)
Changes in assets and liabilities:
Increase (Decrease) in Operating Capital [Abstract]
Accounts receivable
Increase (Decrease) in Accounts Receivable
Inventory
Increase (Decrease) in Inventories
Deferred costs
Increase (Decrease) in Deferred Charges
Prepaid expenses and other current assets
Increase (Decrease) in Prepaid Expense
Other assets
Increase (Decrease) in Other Operating Assets
Deferred income taxes, net
Deferred Income Tax Expense (Benefit)
Accounts payable, accrued expenses and other liabilities
Increase (Decrease) in Accounts Payable and Accrued Liabilities
Deferred revenue
Increase (Decrease) in Deferred Revenue
Other liabilities
Increase (Decrease) in Other Operating Liabilities
Net cash used in operating activities
Net Cash Provided by (Used in) Operating Activities
Cash flows from investing activities:
Net Cash Provided by (Used in) Investing Activities [Abstract]
Capital expenditures
Payments to Acquire Property, Plant, and Equipment
Payment of collateral for commercial surety bond
Payment of collateral for commercial surety bond
The net cash outflow of funds paid as collateral for a commercial surety bond that are classified as investing activities.
Net cash (used in) provided by investing activities
Net Cash Provided by (Used in) Investing Activities
Cash flows from financing activities:
Net Cash Provided by (Used in) Financing Activities [Abstract]
Net proceeds from exercise of warrants and options
Proceeds From Issuance Of Warrants and Options
The cash inflow associated with both the amount received from holders exercising their stock options and issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.
Payment of common stock tendered for employee tax obligations
Payments Related to Tax Withholding for Share-based Compensation
Proceeds from issuance of long-term debt
Proceeds from Issuance of Long-term Debt
Repayments of long-term debt
Repayments of Long-term Debt
Net cash provided by financing activities
Net Cash Provided by (Used in) Financing Activities
Net increase (decrease) in cash and cash equivalents
Cash and Cash Equivalents, Period Increase (Decrease)
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of non-cash financing activities:
Supplemental Cash Flow Information [Abstract]
Reclass of common stock warrant liability to additional paid-in capital upon warrant exercise
Reclass of Common Stock Warrant Liability To Additional Paid In Capital Upon Exercise
Value of reclass of common stock warrant liability to additional paid-in capital upon exercise in noncash financing activities.
Cash and Cash Equivalents, at Carrying Value
Accounts receivable
Total current assets
Property, Plant and Equipment, net
Goodwill
Total assets
Total current liabilities
Total liabilities
Common Stock, Value, Issued
Total stockholders' equity
Total liabilities and stockholders' equity
Research and Development [Abstract]
Number of courses to be delivered
Number of Courses To Be Delivered 1
Number of Arestvyr, also known as ST-246, courses to be delivered to the U.S. Strategic National Stockpile
Value of contract
Government Contract, Value of Award 1
Value of base contract award.
Contract value of development and support activities
Contract Value of Development and Support Activities
Contract value of development and support activities
Option to purchase additional courses
Government Contract, Maximum Number of Additional Courses Available to Purchase
Government contract, maximum number of additional courses available to purchase by the U.S. government, subsequently withdrawn from final contract.
Number of courses under modified contract
Government Contract, Number of Courses Purchased Under Modified Contract
Government contract, number of courses to be purchased under modified contract.
Number of courses manufactured using federal funds
Government Contract, Number of Courses Manufactured Using Federal Funds
Government contract, number of courses to be delivered that were manufactured using federal funds under prior development contracts.
Proceeds from advance payments under the BARDA contract
Proceeds from Advance Payments, Government Contracts
Proceeds from advance payments, government contracts
Milestone payment
Milestone payment
Proceeds from milestone payment, Government contracts
Contract receivable collected, long term contract
Contract Receivable Collected
Amount billed and collected from customers under long-term contracts, including delivered product and reaserch and development. Excludes amounts due that have been withheld because of retainage provisions in a contract.
Research and development revenue long-term contract
Research and Development Revenue Long-term Contract
Revenue earned during the period arising from research and development services provided under the terms of a long-term contract. May include government contracts and any other contract related to a particular project or product.
Contract receivable collected, research and developemnt services
Contract receivable collected, research and developemnt services
Amount billed to customers under long-term contracts or programs and collected for research and development services. Excludes amounts due that have been withheld because of retainage provisions in a contract.
Deferred revenue, additions from BARDA contract
Deferred Revenue, Additions
Number of active contracts
Number of Active Contracts
Number of active contracts.
Number of active grants
Number of Active Grants
Number of active grants
Potential future research and development funding
Potential Future Aggregate Research and Development Expenses
Potential future aggregate research and development funding for specific projects which includes options that may or may not be exercised at the U.S. government's discretion.
Document and Entity Information [Abstract]
Document and Entity Information [Abstract]
Document Information [Table]
Document Information [Table]
Document Information, Document [Axis]
Document Information, Document [Axis]
Document [Domain]
Document [Domain]
Document Information [Line Items]
Document Information [Line Items]
Entity Registrant Name
Entity Registrant Name
Entity Central Index Key
Entity Central Index Key
Current Fiscal Year End Date
Current Fiscal Year End Date
Entity Filer Category
Entity Filer Category
Trading Symbol
Trading Symbol
Document Type
Document Type
Document Period End Date
Document Period End Date
Document Fiscal Year Focus
Document Fiscal Year Focus
Document Fiscal Period Focus
Document Fiscal Period Focus
Amendment Flag
Amendment Flag
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Related Party Transactions [Abstract]
Schedule of Related Party Transactions, by Related Party [Table]
Schedule of Related Party Transactions, by Related Party [Table]
Member of Board of Directors
Management [Member]
Related Party Transaction [Line Items]
Related Party Transaction [Line Items]
Lease property price per month
Lease Property Price Per Month1
Lease property price per month
Free rent period
Free Rent Period
Free Rent Period in months allowed under the sublease.
Monthly rental payments first five years
Monthly Rental Payments First Five Years
The amount of the monthly rental payments due under the sublease entered into for the first five years.
Initial rent period
Initial Rent Period
Represents the number of years for the initial rent period of five years and related monthly payments.
Monthly rental payments after five years
Monthly Rental Payments After Five Years
The amount of the monthly rental payments due under the sublease entered into after the first five years.
Rent period after first five years
Rent Period After First Five Years
Represents the amount of years after the initial rent period of first five years of which monthly rental payments will increase.
Legal fees
Legal Fees
Accounts payable to related party
Accounts Payable, Related Parties
Income Statement [Abstract]
Revenues
Revenues [Abstract]
Operating expenses
Operating Expenses [Abstract]
Total operating expenses
Operating loss
Decrease (increase) in fair value of common stock warrants
Interest expense
Interest Expense
Loss before income taxes
Benefit from income taxes
Net income (loss)
Comprehensive income (loss)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Change in net unrealized gain (loss) on short-term investments
Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax
Comprehensive income (loss)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Antidilutive Securities [Axis]
Antidilutive Securities [Axis]
Antidilutive Securities, Name [Domain]
Antidilutive Securities, Name [Domain]
Stock Options [Member]
Employee Stock Option [Member]
Stock Appreciation Rights (SARs) [Member]
Stock Appreciation Rights (SARs) [Member]
Restricted Stock Units (RSUs) [Member]
Restricted Stock Units (RSUs) [Member]
Warrants [Member]
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted average number
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Weighted average number of shares outstanding, basic and diluted
Procurement Contract and Research Agreements
Procurement Contract and Research Agreements [Text Block]
The entire disclosure for procurement contracts and research agreements including grants or contracts from various agencies of the U.S. government to support the reporting entity's research and development activities.
Loss contingency
Loss Contingency, Accrual, Current
Bonus
Accrued Bonuses, Current
Professional fees
Accrued Professional Fees, Current
Vacation
Accrued Vacation, Current
Other
Other Accrued Liabilities, Current
Total
Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities [Table Text Block]
Tabular disclosure of the components of accrued liabilities and other current liabilities.
Related Party Transactions
Related Party Transactions Disclosure [Text Block]
Equity and Financial Instruments
Financial Instruments Disclosure [Text Block]
Adjustments for Error Corrections [Axis]
Adjustments for Error Corrections [Axis]
Adjustments for Error Correction [Domain]
Adjustments for Error Correction [Domain]
Schedule of Condensed Balance Sheet
Condensed Balance Sheet [Table Text Block]
Schedule of Condensed Income Statement
Condensed Income Statement [Table Text Block]
Fair Value Disclosures
Fair Value Disclosures [Text Block]
Deferred tax assets, net of valuation allowance
Deferred Tax Assets, Net of Valuation Allowance
Deferred tax assets, valuation allowance
Deferred Tax Assets, Valuation Allowance
Taxes payable
Taxes Payable
Tax payment, expected
Tax Payment, Expected
Expected carrying value of obligations incurred and payable for alternative minimum tax.